Skip to main content

UBS Group AG

Position in PLX — Protalix BioTherapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in PLX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$323,045
-$253,164 QoQ
Shares Held
138,646
-47.8% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 101 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in PLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,365,122 across 562 Biotechnology names. PLX ranks #317 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PLX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $323,045 138,646
2026-03-31 $576,209 265,535
2025-12-31 $472,535 262,520
2025-09-30 $422,412 190,276
2025-06-30 $111,222 75,150
2025-03-31 $5,342 2,087
2024-12-31 $34,173 18,178
2024-09-30 $297 292
2024-06-30 $359 307
2024-03-31 $85,624 67,956
2023-12-31 $132,997 74,718
2023-09-30 $61,519 37,060
2023-06-30 $104,080 52,040
2023-03-31 $9,851 4,691
2022-12-31 $164 120
2022-09-30 $11,561 11,118
2022-06-30 $130 120
2022-03-31 $127 120
2021-12-31 $99 120
2021-09-30 $3,077 2,314
2021-06-30 $3,676 1,925
2021-03-31 $9,789 2,195
2020-12-31 $4,345 1,197
2020-09-30 $17,461 4,512
2020-06-30 $13,844 3,653
2020-03-31 $420 179